Similarly, in the ONWARDS 3 [43] study, which focused on insulin-naïve T2DM patients, once-weekly icodec was more effective in reducing HbA1c levels than once-daily degludec after 26 weeks of treatment. Here, INS is linked to type 2 diabetes mellitus.